Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan is a research paper published in mBio (2024). On theSindex it has a DataRank of 0.422. It has been cited 11 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.0496
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
HHS | NIH | National Institute on Drug Abuse
Grant: 1DP2DA049279
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: 1U01AI169587, 1R01AI167653
NIDA NIH HHS
Grant: DP2 DA049279
NIGMS NIH HHS
Grant: R01 GM129325
NIAID NIH HHS
Grant: R01 AI167653
NIAID NIH HHS
Grant: U01 AI169587
FWCI
2.55
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals